Navigation Links
Hi-Lo® Tracheal Tube

ProductsHi-Lo® Tracheal Tube
Company Nellcor
Item Hi-Lo® Tracheal Tube
Features 
  • The Hi-Lo tracheal tube meets or exceeds the guidelines of the cuff criteria.
  • Thin cuff conforms to uneven tracheal surfaces to create low pressure seal.
  • Large cuff diameter of 1-1/2 times the average trachea maintains proper low-pressure seal during tracheal expansion and contraction.
  • High cuff compliance lies close to tube when deflated and expands easily without herniation. Allows more efficient visualization of vocal cords during intubation/extubation.
  • Large cuff resting volume together with long length reduces pressure against tracheal tissue. Offers better protection against aspiration.
  • Low intracuff pressure doesn't restrict tracheal tissue blood flow. Reduces chance of tissue damage, even during long-term intubation.
  • Hooded Murphy tip with eye
  • Full Magill curve
  • Tip-To-Tip® radiopaque line
  • Pilot balloon and mechanical self-sealing valve
  • Packaged sterile
  • Description Indications For Usage:
  • Airway management during surgical procedures
  • Long-term ventilatory management
  • Info Nellcor
    Customer Service: (800) 635-5267
    Web site: http://www.nellcor.com/

    Related medicine products :

    1. Intermediate Hi-Lo® Tracheal Tube
    2. Hi-Lo® Jet Tracheal Tube
    3. Hi-Lo® Evac Endotracheal Tube with Evacuation Lumen
    4. Precut Intermediate Hi-Lo® with Stylet
    5. Hi-Lo® Tracheal Tube with Lanz® Pressure Regulating Valve
    6. Hi-Lo® ES Esophageal Stethoscopes
    7. Uncuffed Tracheal Tube
    8. Nasal RAE® Tracheal Tube
    9. Oral RAE® Tracheal Tube
    10. Reinforced Tracheal Tube
    11. Laser-Flex® Tracheal Tube
    Bard Coude-Tip Latex Urethral Catheter, Two Eyes (Tiemann Model)...
    Red Latex Bardex I.C. Foley 2-Way Catheter (Council Model)...
    The BARDEX I.C. Catheter represents Bard's newest technology in providing protection against NUTI....
    Used for injection into urethral strictures, bladder neck contracture, and the bladder wall. Supplied sterile in peel-open packages. Intended for one-time use....
    Medicine Products:
    (Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, iFitDress.com, the ... for women, has announced its new selection of black ... are on sale now; they are available at discounted prices, ... says, “The promotion will last for three weeks only. You ... market. Those who are interested in our new items can ...
    (Date:12/25/2014)... 25, 2014 BambooFlooringChina.com sells many bamboo ... bamboo flooring. Today, the company announces big discounts ... styles and colors. , BambooFlooringChina.com is the world’s leader ... promotion is valid until Jan. 20, 2015. , The ... woven with a natural thread. All the bamboo strips ...
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... chronic illnesses can receive effective, less expensive care from a ... to a team of dedicated health care professionals, a new ... ill and need either hospitalization or a trip to the ... home clinic at the University of Texas in Houston versus ...
    (Date:12/25/2014)... By Dennis Thompson ... -- Researchers could be closing in on a "fountain of ... improve the health of older adults, a new study suggests. ... when given a drug that targets a genetic signaling pathway ... maker Novartis report. The experimental medication, a ...
    (Date:12/25/2014)... Plugin creators from Pixel Film Studios ... customizable business presentation tool made specifically for Final ... business tool, users can now display their stats and ... Film Studios. “ProFire 5k gives users a multiple options ... to a presentation” , Pixel Film Studios takes the ...
    Breaking Medicine News(10 mins):Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 2Health News:Coordinated Care Through 'Medical Home' Best for Chronically Ill Kids: Study 3Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2
    ... cancers that respond best to tyrosine kinase inhibitors (TKIs), ... according to research presented at the 14th World Conference ... Association for the Study of Lung Cancer (IASLC). ... for non-small cell lung cancer therapy, selecting the best ...
    ... common type of liver cancer, is a leading cause ... options available, they are largely unsuccessful because the disease ... HCC, combined with studies using mice and other animal ... how to diagnose and treat this deadly form of ...
    ... therapy helps ease chronic low back pain and improve function, ... of Internal Medicine will publish in its July 5 ... massage, the trial found that both types of massage worked ... helps people with back pain to function even after six ...
    ... are two to three times more likely to develop a life-threatening ... study published on bmj.com today. The new ... your risk of developing a pulmonary embolism a common cause ... says that, although the risk is small equivalent to seven ...
    ... Recent studies have revealed potato chips and french fries to ... good reason. Have you ever wondered why you can,t eat ... the carbohydrates at fault. UC Irvine researchers Daniele Piomelli, ... make them nearly irresistible and trigger a surprising biological mechanism ...
    ... smoking is associated with a 72% increased risk of ... CMAJ ( Canadian Medical Association Journal ) (pre-embargo link ... cause of serious illness and death in smokers and ... Varenicline is one of the most commonly used drugs ...
    Cached Medicine News:Health News:PET scan with [11C]erlotinib may provide noninvasive method to identify TKI-responsive lung tumors 2Health News:Research in fish provides new clues about deadly form of liver cancer 2Health News:Massage eases low back pain in randomized controlled trial 2Health News:Massage eases low back pain in randomized controlled trial 3Health News:Sitting for long periods doubles risk of blood clots in the lungs 2Health News:Body's natural marijuana-like chemicals make fatty foods hard to resist 2Health News:Varenicline for smoking cessation linked to increased risk of serious harmful cardiac events 2
    (Date:12/24/2014)... TIJUANA, Mexico , Dec. 24, 2014 /PRNewswire/ ... treatment of its first patient in its study ... to the American Stroke Association, ischemic strokes account ... continues to enroll qualified patients in the study, ... Intravenous Administration of Allogeneic Mesenchymal Stem Cells and ...
    (Date:12/24/2014)... -- Commonwealth Cornerstone Group (CCG) today announced the completion of an ... help fund the expansion and consolidation of healthcare services provided ... . PHN is the largest federally qualified ... is the largest employer in Sharon,s ... Currently, PHN Sharon offers scattered services out of ...
    (Date:12/24/2014)... , Dec. 24, 2014 Kinex Pharmaceuticals ... with KX2-361 at Roswell Park Cancer Institute. ... molecule drug that has shown potent inhibitory activity against ... those that are resistant to Temozolomide (T98G), the most ... In a well-established brain tumor mouse model, KX2-361 consistently ...
    Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3